Life Sciences Image Analysis Software sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Image Analysis Software
1.1 - About Life Sciences Image Analysis Software sector
Companies in this space provide AI-driven software to process, quantify, and interpret microscopy and whole‑slide pathology images for research and clinical workflows. Life Sciences Image Analysis Software enables scalable pipelines that automate segmentation, phenotyping, and assay readouts, improving reproducibility and throughput while reducing manual review. Platforms support complex datasets and integrate with upstream acquisition and downstream data systems to deliver decision‑ready results.
Vendors typically offer deep‑learning cell segmentation and detection, tissue classification and quantification for whole‑slide imaging, high‑content screening analytics for plate‑based assays, and 3D/volumetric microscopy analysis with registration and deconvolution. They provide workflow orchestration, batch processing, and audit logging, plus annotation tools and model training/validation. Interoperability includes OME‑TIFF and WSI formats, with APIs to LIMS/ELN and cloud or on‑prem deployments suited for regulated environments.
Primary customers include biopharma R&D teams, clinical pathology laboratories, and contract research organizations. Solutions help strategic buyers in life sciences image analysis accelerate assay readouts, scale high‑throughput screening, and standardize quantitative endpoints across studies. Outcomes typically include improved accuracy and reproducibility, reduced manual annotation time, faster decision cycles in discovery and translational research, and better data governance for compliance and auditability.
2. Buyers in the Life Sciences Image Analysis Software sector
2.1 Top strategic acquirers of Life Sciences Image Analysis Software companies
Paige
- Description: Provider of AI-powered digital pathology software that delivers cloud-based whole-slide analysis to streamline pathologists’ workflows, increase diagnostic confidence and productivity, and support pharmaceutical biomarker discovery for precise cancer treatment.
- Key Products:
- Paige PanCancer: AI whole-slide diagnostic tool flagging lesions across 18 tissue types with 100% sensitivity and 83% specificity to triage routine histology
- Paige Prostate Suite: AI application delivering consistent prostate biopsy diagnosis, reducing ASAP uncertainty and standardizing interpretation for confident management decisions
- Paige Breast Suite: Cloud-based AI system enhancing breast cancer detection, improving diagnostic consistency and accelerating second-reader sign-out for laboratories
- PRISM2: Whole-slide foundation model trained on 2.3 million slides, enabling zero-shot predictions, diagnostic dialogue and clinician-ready reports across cancer types
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Life Sciences Image Analysis Software sector
M&A buyer group 1: Radiology Image Analysis
Sectra
- Type: N/A
- Employees: ●●●●●
- Description: Provider of enterprise medical imaging solutions and professional services, offering a unified platform and modules for radiology, cardiology, pathology, orthopaedics, ophthalmology, genomics and a robust VNA, enabling capture, storage, sharing and collaboration on medical multimedia for 2,500+ healthcare sites worldwide.
- Key Products:
- Enterprise Imaging Portfolio: Unified platform that captures, stores, accesses, shares and enables collaboration around all medical multimedia across the enterprise, improving patient outcomes and lowering operational costs
- Sectra Professional Services: End-to-end technical support, system maintenance, integrations, monitoring and customer training delivered by specialized engineers to maximize system uptime and workflow efficiency
- Sectra Monitoring Service: 24/7 remote server surveillance with automatic alert escalation, trend analysis, disk-space and backup checks, plus rapid disaster recovery to prevent interruptions in mission-critical imaging operations
- Sectra PACS & RIS Modules: Vendor-neutral imaging modules supporting DICOM
- HL7
- IHE MAMMO/MAMMO TOMO, integrating with RIS
- EMR and modalities to manage radiology and other imaging workflows with seamless system interoperability.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Life Sciences Image Analysis Software sector
3.1 - Buyout funds in the Life Sciences Image Analysis Software sector
2.2 - Strategic buyer groups for Life Sciences Image Analysis Software sector
4 - Top valuation comps for Life Sciences Image Analysis Software companies
4.2 - Public trading comparable groups for Life Sciences Image Analysis Software sector
Valuation benchmark group 1: Diagnostic Imaging and Clinical Diagnostics Companies
RadNet
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of diagnostic imaging services and information technology solutions, operating a network of outpatient imaging centers offering services including MRI, CT, PET/CT, X-ray, ultrasound, and mammography to enhance patient care and medical imaging infrastructure.
- Key Products:
- MRI: High-resolution magnetic resonance imaging services for detailed internal body scans
- CT: Computed tomography scans for cross-sectional imaging
- PET/CT: Positron emission tomography combined with CT for comprehensive imaging
- X-ray: Basic and advanced X-ray imaging services for diagnostic purposes
- Mammography: Advanced breast imaging services including digital and 3D mammography.